These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8900582)
1. [cGMP synthesis induced by atrial natriuretic peptide, C-type natriuretic peptide, and nitric oxide in the rat retina]. Moriwaki Y; Kamisaki Y; Itoh T Nippon Ganka Gakkai Zasshi; 1996 Mar; 100(3):187-91. PubMed ID: 8900582 [TBL] [Abstract][Full Text] [Related]
2. Cyclic 3',5'-guanosine monophosphate synthesis induced by atrial natriuretic peptide, C-type natriuretic peptide, and nitric oxide in the rat retina. Moriwaki Y; Kamisaki Y; Itoh T; Nagata M; Tamai A Jpn J Ophthalmol; 1998; 42(4):269-74. PubMed ID: 9749866 [TBL] [Abstract][Full Text] [Related]
3. Regulation of cGMP by soluble and particulate guanylyl cyclases in cultured human airway smooth muscle. Hamad AM; Range S; Holland E; Knox AJ Am J Physiol; 1997 Oct; 273(4):L807-13. PubMed ID: 9357856 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. Calderone A; Thaik CM; Takahashi N; Chang DL; Colucci WS J Clin Invest; 1998 Feb; 101(4):812-8. PubMed ID: 9466976 [TBL] [Abstract][Full Text] [Related]
5. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708 [TBL] [Abstract][Full Text] [Related]
6. Actions of C-type natriuretic peptide and sodium nitroprusside on carbachol-stimulated inositol phosphate formation and contraction in ciliary and iris sphincter smooth muscles. Ding KH; Abdel-Latif AA Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2629-38. PubMed ID: 9375582 [TBL] [Abstract][Full Text] [Related]
7. Regulation of cGMP synthesis in cultured podocytes by vasoactive hormones. Lewko B; Gołos M; Latawiec E; Angielski S; Stepinski J J Physiol Pharmacol; 2006 Dec; 57(4):599-610. PubMed ID: 17229984 [TBL] [Abstract][Full Text] [Related]
8. Cell density modulates the decrease of cytosolic free Ca2+ induced by atrial natriuretic hormone, S-nitroso-N-acetylpenicillamine and 8-bromo cyclic GMP in cultured rat mesangial cells. Lermioglu F; Goyal J; Hassid A Biochem J; 1991 Mar; 274 ( Pt 2)(Pt 2):323-8. PubMed ID: 1848751 [TBL] [Abstract][Full Text] [Related]
10. Cyclic guanosine monophosphate production in the pituitary: stimulation by C-type natriuretic peptide and inhibition by gonadotropin-releasing hormone in alpha T3-1 cells. McArdle CA; Poch A; Käppler K Endocrinology; 1993 May; 132(5):2065-72. PubMed ID: 7682940 [TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic peptide provokes a dramatic increase in cyclic GMP formation and markedly inhibits muscarinic-stimulated Ca2+ mobilisation in SV-40 transformed cat iris sphincter smooth muscle (SV-CISM-2) cells. Ding KH; Ali N; Abdel-Latif AA Cell Signal; 1999 Feb; 11(2):87-94. PubMed ID: 10048785 [TBL] [Abstract][Full Text] [Related]
12. Relaxant effect of C-type natriuretic peptide involves endothelium and nitric oxide-cGMP system in rat coronary microvasculature. Brunner F; Wölkart G Cardiovasc Res; 2001 Aug; 51(3):577-84. PubMed ID: 11476748 [TBL] [Abstract][Full Text] [Related]
14. C-type natriuretic peptide applied to the brain enhances exocrine pancreatic secretion through a vagal pathway. Sabbatini ME; Rodríguez MR; Corbo NS; Vatta MS; Bianciotti LG Eur J Pharmacol; 2005 Nov; 524(1-3):67-74. PubMed ID: 16263110 [TBL] [Abstract][Full Text] [Related]
15. Generation of cyclic guanosine monophosphate in brain slices incubated with atrial or C-type natriuretic peptides: comparison of the amplitudes and cellular distribution of the responses. Gonçalves J; Grove KL; Deschepper CF Regul Pept; 1995 May; 57(1):55-63. PubMed ID: 7644703 [TBL] [Abstract][Full Text] [Related]
16. Presence of functional type B natriuretic peptide receptor in human ocular cells. Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339 [TBL] [Abstract][Full Text] [Related]
17. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices. Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948 [TBL] [Abstract][Full Text] [Related]
18. Localization of natriuretic peptides and their activation of particulate guanylate cyclase and nitric oxide synthase in the retina. Blute TA; Lee HK; Huffmaster T; Haverkamp S; Eldred WD J Comp Neurol; 2000 Sep; 424(4):689-700. PubMed ID: 10931490 [TBL] [Abstract][Full Text] [Related]
19. Effect of ischemia on soluble and particulate guanylyl cyclase-mediated cGMP synthesis in cardiomyocytes. Agulló L; Garcia-Dorado D; Escalona N; Ruiz-Meana M; Inserte J; Soler-Soler J Am J Physiol Heart Circ Physiol; 2003 Jun; 284(6):H2170-6. PubMed ID: 12586638 [TBL] [Abstract][Full Text] [Related]
20. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase. Rodriguez-Pascual F; Miras-Portugal MT; Torres M Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]